The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 16, Issue 8, Pages 707-710
Publisher
Wiley
Online
2014-01-27
DOI
10.1111/dom.12267
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes
- (2013) Guofang Hou et al. BREAST CANCER RESEARCH AND TREATMENT
- Diabetes, metformin use, and colorectal cancer survival in postmenopausal women
- (2013) Furha Iram Cossor et al. Cancer Epidemiology
- A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer
- (2013) S. Spillane et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Metformin inhibits pancreatic cancer cell and tumor growth and downregulates Sp transcription factors
- (2013) V. Nair et al. CARCINOGENESIS
- Association Between Metformin Therapy and Mortality After Breast Cancer: A population-based study
- (2013) I. C. Lega et al. DIABETES CARE
- Metformin reduces recurrence and improves survival in endometrial cancers
- (2013) E. Ko et al. GYNECOLOGIC ONCOLOGY
- Metformin use and endometrial cancer survival
- (2013) Nicole S. Nevadunsky et al. GYNECOLOGIC ONCOLOGY
- Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma
- (2013) Vlad C. Sandulache et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Metformin Use and All-Cause and Prostate Cancer–Specific Mortality Among Men With Diabetes
- (2013) David Margel et al. JOURNAL OF CLINICAL ONCOLOGY
- Metformin and Survival in Pancreatic Cancer
- (2013) Allen L. Hwang et al. PANCREAS
- Metformin does not affect risk of biochemical recurrence following radical prostatectomy: results from the SEARCH database
- (2013) E H Allott et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Clinical pathological characteristics and prognostic analysis of diabetic women with luminal subtype breast cancer
- (2013) Yuanting Xiao et al. TUMOR BIOLOGY
- Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma
- (2013) Malte Rieken et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Effect of metformin on prostate cancer outcomes after radical prostatectomy
- (2013) Dharam Kaushik et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The effect of metformin and thiazolidinedione use on lung cancer in diabetics
- (2012) Peter J Mazzone et al. BMC CANCER
- Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
- (2012) C R Garrett et al. BRITISH JOURNAL OF CANCER
- Metformin intake is associated with better survival in ovarian cancer
- (2012) Sanjeev Kumar et al. CANCER
- Metformin Use Is Associated with Better Survival of Diabetic Patients with Pancreatic Cancer
- (2012) N. Sadeghi et al. CLINICAL CANCER RESEARCH
- Mortality After Incident Cancer in People With and Without Type 2 Diabetes: Impact of metformin on survival
- (2012) C. J. Currie et al. DIABETES CARE
- Metformin and Prostate Cancer: Reduced Development of Castration-resistant Disease and Prostate Cancer Mortality
- (2012) Daniel E. Spratt et al. EUROPEAN UROLOGY
- Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
- (2012) Zhi-Jiang Zhang et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical Outcomes of Chemotherapy for Diabetic and Nondiabetic Patients With Pancreatic Cancer
- (2012) Yousuke Nakai et al. PANCREAS
- Metformin and cancer: from the old medicine cabinet to pharmacological pitfalls and prospects
- (2012) Arian Emami Riedmaier et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer
- (2011) X. He et al. ANNALS OF ONCOLOGY
- Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients
- (2011) X.- X. He et al. ANNALS OF ONCOLOGY
- Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes
- (2011) Ben-Xu Tan et al. CANCER
- Effect of metformin on survival outcomes in diabetic patients with triple receptor-negative breast cancer
- (2011) Soley Bayraktar et al. CANCER
- Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
- (2011) Z.-J. Zhang et al. DIABETES CARE
- The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus
- (2011) Jin Ha Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Metformin associated with lower mortality in diabetic patients with early stage hepatocellular carcinoma after radiofrequency ablation
- (2011) Tsung-Ming Chen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Relationship of Type II Diabetes and Metformin Use to Ovarian Cancer Progression, Survival, and Chemosensitivity
- (2011) Iris L. Romero et al. OBSTETRICS AND GYNECOLOGY
- Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase
- (2010) Carolyn Algire et al. ENDOCRINE-RELATED CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now